Jesper Ericsson named new Chief Executive Officer by Symcell Sverige ABSymcel announced that Jesper Ericsson has joined Symcel as Chief Executive Officer. more ➔
MDx Health hires Michael Brawer as CMOBelgian diagnostics company MDxHealth SA has appointed Michael K. Brawer, MD as Chief Medical Officer to prepare the company for growth in H2/17 and beyond. The urologist and former professor of … more ➔
New CFO for Pharmalink Swedish specialty pharmaceutical company Pharmalink AB Stockholm has Fredrik Johansson as new Chief Financial Officer. more ➔
Orchard Therapeutics appoints Mark Rothera as CEOGene therapy specialist Orchard Therapeutics (London) has appointed Mark Rothera as President and Chief Executive Officer, a specialist for the commercialisation of novel treatments and business dev … more ➔
Uniqure’s new COO to oversee GMPGene therapy specialist Uniqure NV announced new executive appointments to its leadership team and nominations to its Board of Directors. Scott McMillan, for instance, will be responsible for all current … more ➔
Autolus: Accelerating T-cell productsIn preparation for the development and commercialisation of Autolus’ T-cell products, the London based company announced four new senior leadership appointments. more ➔
Adocia: Advancing diabetes portfolioFollowing Novo Nordisk, Dr. Stanislav Glezer has joined the French biopharmaceutical company Adocia as the new Chief Medical Officer. He will be responsible for designing and executing the clinical development … more ➔
Myovant strengthens executive teamSwiss-based pharmaceutical company Myovant Sciences Ltd. is adding four new executives. Among them is a new Chief Medical Director, Juan Camilo Arjona Ferreira. In addition, the company increases its … more ➔
GSK expands its board with renowned cancer scientistBritish pharma company GlaxoSmithKline plc. is expanding its company board and announced Laurie Glimcher as a non-executive director. Glimcher will join the board on 1 September. more ➔
Sygnis AG: Science and business rolled into oneGerman-Spanish biotech Sygnis AG has made changes to its management team and supervisory board. Heikki Lanckriet, who was previously Co-CEO, will become sole CEO of Sygnis and will also retain his role … more ➔
